2011
DOI: 10.1182/asheducation-2011.1.391
|View full text |Cite
|
Sign up to set email alerts
|

Acquired Disorders of Platelet Function

Abstract: Platelet dysfunction is commonly acquired due to medications, procedures, medical conditions, and underlying hematologic disease. These issues are presented, the data reviewed, and recommendations given herein. Many medications and dietary supplements have platelet-inhibitory effects in vitro, although the clinical effects on bleeding risks are unclear for many. Platelet-inhibitory drugs are key in the treatment of vascular disease. Data are available to aid in the management of these medications to prevent he… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
49
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(51 citation statements)
references
References 36 publications
1
49
0
1
Order By: Relevance
“…dilution of platelet numbers resulting from transfusion of platelet-poor blood can cause this condition [15]. Disorders of platelet adhesion, idiopathic alpha, disorders of platelet granules [16] or acquired platelet function disorders including medication and chemicals, chronic kidney disease and myeloproliferative disorders cause platelet function disorders that may be inherited [17]. Emergent plasma exchange is the cornerstone of TTP treatment [18], while short "pulses" of dexamethasone have been found to be very effective in initial management of immune thrombocytopenia [19].…”
Section: Determination Of Hematological Parametersmentioning
confidence: 99%
“…dilution of platelet numbers resulting from transfusion of platelet-poor blood can cause this condition [15]. Disorders of platelet adhesion, idiopathic alpha, disorders of platelet granules [16] or acquired platelet function disorders including medication and chemicals, chronic kidney disease and myeloproliferative disorders cause platelet function disorders that may be inherited [17]. Emergent plasma exchange is the cornerstone of TTP treatment [18], while short "pulses" of dexamethasone have been found to be very effective in initial management of immune thrombocytopenia [19].…”
Section: Determination Of Hematological Parametersmentioning
confidence: 99%
“…There are two isoforms of COXs: COX-1 and COX-2. COX-1 is expressed constitutively in most tissues; COX-2 is induced by stimuli such as bacterial lipopolysaccharide (LPS) and cytokines [30][31][32]. 5-LOX catalyzing AA pathway results in the generation of leukotrienes (LTs) which are also actively involved in inflammatory diseases [33].…”
Section: Introductionmentioning
confidence: 99%
“…5 Different medications responsible for platelet interference are nitrates, beta-lactam antibiotics, beta-blockers, nitrates, tricyclic antidepressants; etc. 6 Heparin exposure can also lead to life-threatening thrombocytopenia. 7 Immune-mediated disorders (e.g.…”
Section: Thrombocytopeniamentioning
confidence: 99%